Antifolates

Results: 84



#Item
511 • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for

1 • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-01-22 11:18:48
5221462 Pemetrexed Clinpharm BPCA

21462 Pemetrexed Clinpharm BPCA

Add to Reading List

Source URL: www.fda.gov

Language: English
53OC PAC March[removed]Almita Safety Review

OC PAC March[removed]Almita Safety Review

Add to Reading List

Source URL: www.fda.gov

Language: English
54FOOD AND DRUG ADMINISTRATION

FOOD AND DRUG ADMINISTRATION

Add to Reading List

Source URL: www.fda.gov

Language: English
551 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyop

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyop

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-10-17 16:09:28
56HIGHLIGHTS OF PRESCRIBING INFORMATION  -------------------------------CONTRAINDICATIONS------------------------------ These highlights do not include all the information needed to use ALIMTA safely and effectively. See f

HIGHLIGHTS OF PRESCRIBING INFORMATION -------------------------------CONTRAINDICATIONS------------------------------ These highlights do not include all the information needed to use ALIMTA safely and effectively. See f

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:09:48
571 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-09-17 10:57:35
58  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VORAXAZE® safely and effectively. See full prescribing information for VORAXAZE®.

 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VORAXAZE® safely and effectively. See full prescribing information for VORAXAZE®.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-04-01 15:23:37
59

PDF Document

Add to Reading List

Source URL: www.cafc.uscourts.gov

Language: English - Date: 2012-08-24 10:58:58
60December 3, 2002  ISMP SpecialAlert

December 3, 2002 ISMP SpecialAlert

Add to Reading List

Source URL: www.ismp.org

Language: English - Date: 2005-08-01 14:54:52